Pay in 4 interest-free payments of $5.48 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Toxicology International, 24(1), 65-73
Top-Line Summary: REDEFINE 4 (CagriSema vs Tirzepatide) - - - CagriSema: 23.0% weight loss (efficacy estimand) Tirzepatide: 25.5% weight loss Treatment-regimen estimand: CagriSema 20.2% Tirzepatide 23.6% Primary endpoint: Not met (non-inferiority) Safety: Mostly GI AEs, consistent with class Perspective: A therapy producing ~23% weight loss is framed as missing. Thats how far obesity pharmacotherapy has progressed
Studies have also linked herbal supplements used for weight loss with miscarriage
for example, in cancer patients underg
US$ 23.84
US$ 22.23
US$ 29.10
US$ 27.66
US$ 22.25
US$ 29.67
